AlphaValue/Baader Europe on Tuesday downgraded Swiss drugmaker Sandoz Group (SDZ.SW) to reduce from add and decreased its price target to 77.90 francs from 78.10 francs.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)